Actualités 17 Abr 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News 10 Ene 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News 17 Abr 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
Actualités 14 Ago 2023 L’écosystème florissant de Berne pour l’innovation en sciences de la vie Au cœur de la Suisse occidentale, le canton de Berne s'est imposé comme une destination de choix pour les entreprises du secteur des sciences de ...
Aktuell 06 Jun 2023 Novocure spendet 3 Millionen Dollar für Krebsforschung Das Onkologieunternehmen Novocure wird Conquer Cancer über drei Jahre mit jeweils 1 Million Dollar unterstützen. Die Mittel sollen von der Stiftu...
News 29 Sep 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
News 06 Jun 2023 Novocure to donate 3 million US dollars to cancer research Novocure, a biotechnology firm specializing in the field of oncology, has pledged support of 1 million US dollars per year for a period of three ...
News 14 Ago 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
News 29 Feb 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
News 01 Feb 2022 Merck acquires Geneva-based biopharmaceutical company Chord Therapeutics Chord Therapeutics, a clinical stage biopharmaceutical company developing drugs for rare neuroinflammatory diseases, is being acquired by Merck.
News 29 Ene 2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
News 06 Nov 2023 Vaud-based LAGOSTA and global giant Merck collaborate on chitosan distribution Biotech company LAGOSTA has announced a collaboration with Merck. The partnership aims to facilitate the distribution of LAGOSTA's superior chito...
News 06 Nov 2023 Abionic and Lascco partner with Fapon for sepsis diagnosis in China Biopôle companies Abionic and Lascco team up with Fapon to harness a groundbreaking biomarker for sepsis detection, enhancing early diagnosis cap...
News 07 Ago 2023 CDR-Life receives milestone payment CDR-Life has reached a second milestone linked to the development of its drug to combat an irreversible retinal disease. This entitles the biotec...
News 26 Jul 2023 LimmaTech Bio cooperating with GSK on vaccine development The biotechnology firm LimmaTech Biologics has concluded a license agreement with GlaxoSmithKline Biologicals (GSK). In this way, LimmaTech is se...
News 31 Jul 2023 InSphero announces an award for 3D in vitro models InSphero, based in the canton of Zurich, and the Physicians Committee for Responsible Medicine have launched a joint award program. Five academic...